The glutamine catabolism pathway is initiated by the conversion of glutamine to glutamate by glutaminase (GLS)1, and several studies have shown that GLS1 inhibition significantly suppresses cancer cell proliferation [28–31]. The gene discussed is GLS; the disease is cancer.